Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Cash from Investing Activities (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$14000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 101.06% year-over-year to -$14000.0; the TTM value through Dec 2025 reached -$102000.0, down 100.27%, while the annual FY2025 figure was -$102000.0, 100.27% down from the prior year.
  • Cash from Investing Activities hit -$14000.0 in Q4 2025 for Sangamo Therapeutics, up from -$64000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $89.3 million in Q2 2021 and bottomed at -$13.5 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is $26.2 million, with a median of $35.7 million recorded in 2023.
  • Year-over-year, Cash from Investing Activities soared 1995.48% in 2023 and then tumbled 127.47% in 2025.
  • Sangamo Therapeutics' Cash from Investing Activities stood at $52.6 million in 2021, then decreased by 19.04% to $42.6 million in 2022, then fell by 11.51% to $37.7 million in 2023, then tumbled by 96.49% to $1.3 million in 2024, then tumbled by 101.06% to -$14000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$14000.0, -$64000.0, and -$24000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.